<p>ND: non-diagnostic, BE: benign, IND: indeterminate, SUSP: suspicious for malignancy, MAL: malignancy, cPTC: conventional papillary thyroid carcinoma, FVPTC: follicular variant of papillary thyroid carcinoma</p
BACKGROUND: The indications of repeat fine-needle aspiration (FNA) for thyroid nodules with benign r...
Aim. We aimed to analyze the diagnostic criteria proposed by the Bethesda System for Reporting Thyro...
<p>(<b>A</b>) The malignancy rate was estimated to be 7–35% in AUS-A nodules and 28–49% in FN/SFN no...
<p>BN: benign; CA: carcinoma; PPV, positive predictive value; NPV, negative predictive value.</p
The benign category of the Bethesda System for reporting thyroid cytopathology (BSRTC) predicts an i...
Background This study was performed to analyze cytologic diagnosis of noninvasive follicular thyroid...
BACKGROUND:The follicular variant of papillary thyroid cancer (FVPTC), especially the encapsulated n...
The new fourth edition of the WHO classification of tumors of endocrine organs published by the Inte...
PURPOSE: To evaluate the malignancy risks of thyroid nodules with nondiagnostic results at ultrasono...
The indeterminate thyroid nodules diagnosed by fine-needle aspiration cytology (FNAC)represents a pr...
While the reported “incidence ” of thyroid cancer is increasing, the mortality from thyroid cancer h...
The indeterminate thyroid nodules diagnosed by fine-needle aspiration cytology (FNAC)represents a pr...
The follicular variant of papillary thyroid cancer (FVPTC), especially the encapsulated non-invasive...
Hypothesis: Clinical or cytologic factors predictive of malignancy can be identified and incorporate...
We propose a new classification of thyroid follicular cell tumors which is correlated with patient&a...
BACKGROUND: The indications of repeat fine-needle aspiration (FNA) for thyroid nodules with benign r...
Aim. We aimed to analyze the diagnostic criteria proposed by the Bethesda System for Reporting Thyro...
<p>(<b>A</b>) The malignancy rate was estimated to be 7–35% in AUS-A nodules and 28–49% in FN/SFN no...
<p>BN: benign; CA: carcinoma; PPV, positive predictive value; NPV, negative predictive value.</p
The benign category of the Bethesda System for reporting thyroid cytopathology (BSRTC) predicts an i...
Background This study was performed to analyze cytologic diagnosis of noninvasive follicular thyroid...
BACKGROUND:The follicular variant of papillary thyroid cancer (FVPTC), especially the encapsulated n...
The new fourth edition of the WHO classification of tumors of endocrine organs published by the Inte...
PURPOSE: To evaluate the malignancy risks of thyroid nodules with nondiagnostic results at ultrasono...
The indeterminate thyroid nodules diagnosed by fine-needle aspiration cytology (FNAC)represents a pr...
While the reported “incidence ” of thyroid cancer is increasing, the mortality from thyroid cancer h...
The indeterminate thyroid nodules diagnosed by fine-needle aspiration cytology (FNAC)represents a pr...
The follicular variant of papillary thyroid cancer (FVPTC), especially the encapsulated non-invasive...
Hypothesis: Clinical or cytologic factors predictive of malignancy can be identified and incorporate...
We propose a new classification of thyroid follicular cell tumors which is correlated with patient&a...
BACKGROUND: The indications of repeat fine-needle aspiration (FNA) for thyroid nodules with benign r...
Aim. We aimed to analyze the diagnostic criteria proposed by the Bethesda System for Reporting Thyro...
<p>(<b>A</b>) The malignancy rate was estimated to be 7–35% in AUS-A nodules and 28–49% in FN/SFN no...
DOI
Add to ORKG